Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

C4 Therapeutics CFO Reports RSU Vesting and Tax Withholding

Kendra Adams, Chief Financial Officer of C4 Therapeutics, Inc., filed a Statement of Changes in Beneficial Ownership on September 21, 2026, reporting two transactions in the company's common stock dated September 18, 2026.

Manish Choudhary | 21 September 2026

PHINIA Inc. Officer Acquires 22 Shares via Dividend Reinvestment

Pedro Rui Neto de Abreu, President, Power Systems at PHINIA INC. (NYSE:PHIN), filed a Form 4 on September 21, 2026, reporting the acquisition of 22 shares of common stock on September 18, 2026, through automatic dividend reinvestment on outstanding equity awards.

Vinay Lochav | 21 September 2026

Ulta Beauty CEO Sells 2,000 Shares of Common Stock

Kecia Steelman, President and CEO of Ulta Beauty, Inc. (NASDAQ:ULTA), filed a Form 4 on September 21, 2026, disclosing the sale of 2,000 shares of common stock on September 17, 2026.

Vinay Lochav | 21 September 2026

NeuroPace CFO Reports Share Withholding for Tax Obligations

Patrick F. Williams, Chief Financial Officer of NeuroPace Inc, filed a Form 4 on September 21, 2026, disclosing the disposition of 1,162 shares of common stock on September 20, 2026, to satisfy tax withholding obligations connected to a vesting restricted stock unit award.

Shwetambri Chauhan | 21 September 2026

Equitable Holdings Director Sells 2,780 Shares

A Form 4 filed on September 21, 2026, reports that Bertram L. Scott, a director of Equitable Holdings, Inc. (NYSE:EQH), sold 2,780 shares of common stock on September 21, 2026.

Aakashdeep | 21 September 2026

Enliven Therapeutics CFO Exercises Options and Sells Shares

Benjamin Hohl, Chief Financial Officer of Enliven Therapeutics, Inc. (NASDAQ:ELVN), filed a Form 4 on September 21, 2026, disclosing a stock option exercise and the sale of 6,018 shares of common stock on September 17, 2026, pursuant to a Rule 10b5-1 trading plan.

Nitish Kishor | 21 September 2026

Enliven Therapeutics CMO Sells Shares After Option Exercise

Helen Louise Collins, Chief Medical Officer of Enliven Therapeutics, Inc., filed a Form 4 on September 21, 2026, reporting an option exercise and the sale of common stock on September 17, 2026, pursuant to a Rule 10b5-1 trading plan.

Anjali Anand | 21 September 2026

Service Properties Trust CEO Reports Share Withholding

Christopher J. Bilotto, President and Chief Executive Officer of Service Properties Trust, filed a statement of changes in beneficial ownership on September 21, 2026, reporting a transaction dated September 17, 2026.

Nitish Kishor | 21 September 2026

Venture Global CFO Exercises Options, Sells 222,222 Shares

Jonathan W. Thayer, Chief Financial Officer of Venture Global, Inc., filed a Form 4 on September 21, 2026, disclosing the exercise of stock options and the sale of 222,222 shares of Class A Common Stock across two trading days.

Aditi Sarkar | 21 September 2026

Service Properties Trust CFO Reports Share Withholding

Brian E. Donley, CFO and Treasurer of Service Properties Trust, filed a Form 4 on September 21, 2026, disclosing a September 17, 2026 transaction involving the withholding of common shares to satisfy a tax liability upon a security vesting.

Shwetambri Chauhan | 21 September 2026
Support

Hi! How can we help you today?

Loading…